Skip to main content
OpenTrials
Active, Not Recruiting

NCT Number: NCT04113044

Go Fit Fast, Recovery Trajectory Using PROMIS®, Linking PROMIS®

Prospective data will be collected in approximately 3500 patients (700 per 5 injury groups).

Patients will be followed up according to the standard (routine) for up to 1 year after the treatment.

Data collection will include underlying disease, treatment details, patient reported outcomes (PROs), anticipated or procedure-related adverse events (i.e. complications), and radiological outcomes.

Active, Not Recruiting

This study is active but is not currently recruiting participants.

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Univ.-Klinik für Orthopädie und Traumatologie, Innsbruck, Austria

Loading trial locations.

About this study

More in detail this observational study includes the following sub-projects:

I) Weight -bearing and Gait Observation for Fully Individualized Treatment and Aftercare Following Surgery and Trauma

Objectives:

To analyse the association between automated, sensor-based patient activity and loading data, and clinical (Patient Reported Outcomes [PROs]) and radiographic outcome during fracture healing.

II) Recovery Trajectory using PROMIS®: Defining the Recovery Trajectory using PROMIS® to Optimize Decision-making and Outcomes following Extremity Fractures

Objectives:

  • To identify the factors predictive of longer term magnitude of limitations after extremity fractures (using PROMs)
  • To assess minimal clinically important difference (MCID) and substantial clinical benefit (SCB) in PROM scores
  • To define recovery trajectories of PROMs i.e. range, normative limits and score thresholds

III) Linking PROMIS®: Linking of PROMIS Measures to Legacy Measures in an Orthopaedic Patient Population

Objectives:

  • Administer and collect responses to the PROMIS PF/UE and PAIN INT and the four orthopaedic legacy measures in the same group of orthopaedic trauma patients.
  • Apply the methods of item-response theory (IRT) linking to establish a common standardized metric.
  • Develop equations for conversion of a PROMIS PF/UE and PAIN INT score to each of the specified legacy measures and vice-versa.

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age 18 years and older
  • Diagnosis of one of, isolated injury
  • Hip fracture
  • Tibial shaft fracture (with and without associated fibular fracture)
  • Ankle/pilon fracture
  • Proximal humerus fracture
  • Distal radius fracture
  • English, German, or Spanish speaking
  • Informed consent obtained, i.e.:
  • Ability to understand the content of the patient information/ICF
  • Willingness and ability to participate in the clinical investigation according to the Clinical Investigation Plan (CIP)
  • Signed and dated EC/IRB approved written informed consent

Exclusion criteria

  • More than 21 days from day of injury to day of surgery / day of nonoperative treatment decision
  • Patients with multiple fractures
  • Pathological fractures due to cancer
  • Recent history of substance abuse (i.e. recreational drugs, alcohol) that would preclude reliable assessment
  • Pregnancy or women planning to conceive within the study period
  • Patients who are not able to provide independent written informed consent unless defined and IRB/IEC-approved procedures for consenting such vulnerable patients are in place
  • Prisoners
  • Participation in any other medical device or medicinal product study within the previous month that could influence the results of the present study
  • Patients unable to likely achieve anticipated Follow-up (FU)

Treatment and study plan

All treatments will remain the standard (routine) care procedures based on individual clinician's judgment and the patient characteristics.

Other

All treatments will remain the standard (routine) care procedures based on individual clinician's judgment and the patient characteristics.

Other names: Patient Reported Outcomes

Primary outcomes

  1. Go Fit Fast: Radiographic measurements, Patient related outcomes (PROs: PROMIS, HOOS, KOOS,), Loading/Activity pattern analysis

    Time frame: from the pre-treatment assessment until 12 months after the treatment (surgical or not-surgical)

    • Radiographic measurements

    o Healing (Radiographic Union Score in Tibia Fractures [RUST]/ Radiographic Union Score in Hip Fractures [RUSH])

    • Patient related outcomes
    • Patient Reported Outcome Measurement Information System (PROMIS): Physical Function (PF) short form Custom AO14 Pain Interference
    • Hip Disability and Osteoarthritis Outcome Score (HOOS-12) (assessing short- and long-term symptoms and function in hip injuries; the lower score indicates higher symptoms)
    • Knee Injury and Osteoarthritis Outcome Score (KOOS-12) (assessing short- and long-term symptoms and function in knee injuries; the lower score indicates higher symptoms)
    • Loading/Activity pattern analysis:
    • Number of steps with weight-bearing >80% body-weight (weight in kg)
    • pressure distribution [N/cm2]
    • center of pressure [mm]
    • ground reaction forces [N]
    • temporal and spatial parameters (time spent during gait [min], stance time [s], swing time [s], double support time [s], cadence [r/min], cycle time [s])
  2. Recovery Trajectories PROMIS/Linking PROMIS: PROs: PROMIS, HOOS, KOOS, QuickDASH, FAAM

    Time frame: from the pre-treatment assessment until 12 months after the treatment (surgical or not-surgical)

    PROs that measure physical limitations:

    • PROMIS PF Short Form Custom AO14 (questions that cover the domain of physical function/mobility from self-care to strenuous activities)
    • PROMIS Upper Extremity (UE) Short Form Custom AO8 (questions assessing arm and hand specific limitations, e.g. difficulty writing, lifting heavy objects; a higher score indicates a better function)
    • Disabilities of the Arm, Shoulder, and Hand (QuickDASH) (11 questions assessing outcomes in upper extremity disorders; a higher score indicates a greater disability)
    • HOOS-12
    • KOOS-12
    • Foot and Ankle Ability Measure (FAAM) (21 items of activities of daily living subscale)
    • PROMIS Global Health (10 questions assessing physical health, mental health, and social health; a higher score indicates a better general health)

Secondary outcomes

  1. PROMIS Pain Interference

    Time frame: from the treatment assessment until 12 months after the treatment (surgical or not-surgical)

    PROMIS Pain Interference (8 questions) assesses the impact of pain on common activities of daily life including social, cognitive, emotional, physical, and recreational aspects. The higher score represents a higher pain level

  2. PROMIS Depression

    Time frame: from the treatment assessment until 12 months after the treatment (surgical or not-surgical)

    PROMIS Depression assesses negative mood (sadness, guilt), views of self (worthlessness, self-criticism) and diminished positive affect and engagement (loss of interest) within the previous week. The higher score represents higher depression level

  3. PROMIS Anxiety

    Time frame: from the treatment assessment until 12 months after the treatment (surgical or not-surgical)

    PROMIS Anxiety assesses levels of anxiety through measuring aspects of fear (e.g. fearfulness, feelings of panic), anxious misery (e.g. worry, dread), hyperarousal (e.g. tension, nervousness, restless) and some somatic symptoms related to arousal (e.g. dizziness). The higher score represent the higher level of anxiety

  4. PROMIS Ability to Participate in Social Roles and Activities

    Time frame: from the treatment assessment until 12 months after the treatment (surgical or not-surgical)

    PROMIS Ability to Participate in Social Roles and Activities item bank assesses the perceived ability to perform one's usual social roles and activities. The higher score represents better ability for social roles

  5. Pain Self-Efficacy Questionnaire (PSEQ)-2

    Time frame: from the treatment assessment until 12 months after the treatment (surgical or not-surgical)

    PSEQ-2 assesses adaptive coping strategy and the confidence one can achieve one's goals in spite of pain. Items are scored on a 7-point Likert scale and added to form a total score ranging from 0 to 12, with higher scores indicating greater self-efficacy

  6. Patient Activation Measure (PAM)-10

    Time frame: from the treatment assessment until 12 months after the treatment (surgical or not-surgical)

    PAM-10 assesses activation and the personal and psychological competencies. PAM segments individuals into one of four activation levels along an empirically derived 100-point scale. Individuals in the highest activation level are proactive with their health, have developed strong self-management skills, and are resilient in times of stress or change.

  7. Cognitive assessment

    Time frame: Pre-treatment

    The MiniCog is a 3-minute instrument assessing cognitive impairment. It consists of two components, a 3-item recall test for memory and a simply scored clock drawing test. A total score ranges from 0 to 5. A score of zero, one or two out of five points in total, indicates a concern in cognitive functioning.

  8. Mobility Scores

    Time frame: Pre-treatment

    Parker Mobility Scale assess the patient's ability to perform indoor walking, outdoor walking, and shopping before the fracture. A score ranges between 0 and 3 (0 = not at all, 1 = with help from another person, 2 = with an aid, and 3 = no difficulty and no aid) for each function, resulting in a total score ranging from 0 (no walking ability at all) to 9 (fully independent).

  9. RUSH score

    Time frame: from the 6-8 weeks until 12 months after the treatment (surgical or not-surgical)

    Radiographic Union Score in Hip Fractures

  10. RUST score

    Time frame: from the 6-8 weeks until 12 months after the treatment (surgical or not-surgical)

    Radiographic Union Score for Tibia

  11. Numeric Rating Scale (NRS) Pain

    Time frame: from the treatment assessment until 12 months after the treatment (surgical or not-surgical)

    An ordinal scale from 0 to 10 with 0 indicating no pain and 10 indicating extreme pain.

Sponsors and collaborators

Lead sponsor

AO Innovation Translation Center

Other

Registry information

Official study title

Clinical Priority Program (CPP) Clinical Outcome Measurement of Fracture Treatment:

Important dates

Study start
2021
Primary completion
2026
Study completion
2026
First posted
Oct 2, 2019
Registry last updated
Mar 6, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.